|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
35,410,000 |
Market
Cap: |
13.82(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$202.16 - $413.31 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 463 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
34 |
Total Shares Sold |
1,827,736 |
2,490,136 |
3,605,616 |
3,694,042 |
Total Sell Value |
$734,360,254 |
$918,029,204 |
$1,190,266,600 |
$1,209,941,112 |
Total People Sold |
6 |
6 |
8 |
8 |
Total Sell Transactions |
45 |
71 |
88 |
95 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Medpace Investors, Llc |
10% Owner |
|
2020-08-05 |
4 |
AS |
$125.04 |
$1,647,902 |
D/D |
(13,179) |
7,112,203 |
|
16% |
|
Troendle August J. |
President & CEO |
|
2020-08-04 |
4 |
AS |
$124.43 |
$5,660,072 |
I/I |
(45,488) |
7,125,382 |
|
16% |
|
Medpace Investors, Llc |
10% Owner |
|
2020-08-04 |
4 |
AS |
$124.43 |
$5,660,072 |
D/D |
(45,488) |
7,125,382 |
|
16% |
|
Medpace Investors, Llc |
10% Owner |
|
2020-08-03 |
4 |
AS |
$124.13 |
$3,352,131 |
D/D |
(27,005) |
7,170,870 |
|
12% |
|
Troendle August J. |
President & CEO |
|
2020-08-03 |
4 |
AS |
$124.13 |
$3,352,131 |
I/I |
(27,005) |
7,170,870 |
|
12% |
|
Medpace Investors, Llc |
10% Owner |
|
2020-07-31 |
4 |
AS |
$118.17 |
$4,682,132 |
D/D |
(39,622) |
7,197,875 |
|
17% |
|
Troendle August J. |
President & CEO |
|
2020-07-31 |
4 |
AS |
$118.17 |
$4,682,132 |
I/I |
(39,622) |
7,197,875 |
|
17% |
|
Burwig Susan E |
Exec. VP, Operations |
|
2020-07-30 |
4 |
S |
$121.14 |
$726,840 |
D/D |
(6,000) |
46,179 |
|
-17% |
|
Medpace Investors, Llc |
10% Owner |
|
2020-07-30 |
4 |
AS |
$120.79 |
$5,188,534 |
D/D |
(42,955) |
7,237,497 |
|
17% |
|
Troendle August J. |
President & CEO |
|
2020-07-30 |
4 |
AS |
$120.79 |
$5,188,534 |
I/I |
(42,955) |
7,237,497 |
|
17% |
|
Medpace Investors, Llc |
10% Owner |
|
2020-07-29 |
4 |
AS |
$123.99 |
$5,840,673 |
D/D |
(47,106) |
7,280,452 |
|
11% |
|
Troendle August J. |
President & CEO |
|
2020-07-29 |
4 |
AS |
$123.99 |
$5,840,673 |
I/I |
(47,106) |
7,280,452 |
|
11% |
|
Troendle August J. |
President & CEO |
|
2020-07-28 |
4 |
AS |
$127.23 |
$27,290,708 |
I/I |
(214,499) |
7,327,558 |
|
14% |
|
Medpace Investors, Llc |
10% Owner |
|
2020-07-28 |
4 |
AS |
$127.23 |
$27,290,708 |
D/D |
(214,499) |
7,327,558 |
|
14% |
|
Troendle August J. |
President & CEO |
|
2020-07-27 |
4 |
AS |
$110.43 |
$3,204,568 |
I/I |
(29,019) |
7,542,057 |
|
22% |
|
Medpace Investors, Llc |
10% Owner |
|
2020-07-27 |
4 |
AS |
$110.43 |
$3,204,568 |
D/D |
(29,019) |
7,542,057 |
|
22% |
|
Medpace Investors, Llc |
10% Owner |
|
2020-07-24 |
4 |
AS |
$106.13 |
$3,648,749 |
D/D |
(34,380) |
7,571,076 |
|
30% |
|
Troendle August J. |
President & CEO |
|
2020-07-24 |
4 |
AS |
$106.13 |
$3,648,749 |
I/I |
(34,380) |
7,571,076 |
|
30% |
|
Medpace Investors, Llc |
10% Owner |
|
2020-07-23 |
4 |
AS |
$111.83 |
$3,549,820 |
D/D |
(31,743) |
7,605,456 |
|
20% |
|
Troendle August J. |
President & CEO |
|
2020-07-23 |
4 |
AS |
$111.83 |
$3,549,820 |
I/I |
(31,743) |
7,605,456 |
|
20% |
|
Troendle August J. |
President & CEO |
|
2020-07-22 |
4 |
AS |
$109.99 |
$3,946,221 |
I/I |
(35,878) |
7,637,199 |
|
17% |
|
Medpace Investors, Llc |
10% Owner |
|
2020-07-22 |
4 |
AS |
$109.99 |
$3,946,221 |
D/D |
(35,878) |
7,637,199 |
|
17% |
|
Troendle August J. |
President & CEO |
|
2020-07-21 |
4 |
AS |
$106.78 |
$2,999,450 |
I/I |
(28,090) |
7,673,077 |
|
23% |
|
Medpace Investors, Llc |
10% Owner |
|
2020-07-21 |
4 |
AS |
$106.78 |
$2,999,450 |
D/D |
(28,090) |
7,673,077 |
|
23% |
|
Medpace Investors, Llc |
10% Owner |
|
2020-07-20 |
4 |
AS |
$105.47 |
$1,870,510 |
D/D |
(17,735) |
7,701,167 |
|
22% |
|
533 Records found
|
|
Page 17 of 22 |
|
|